5-Star Rating from Doody's Review Service   l    2021, 2022 Doody's Core Titles List Selection

"...for ease of finding information in a single book, this publication tops the list. ASHP is the best group to provide this type of data to anyone involved in the sterile compounding of parenteral drugs."
Lawrence P Carey, BS, PharmD

ASHP’s New and Expanded Guide to IV Compatibility & Stability

For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP^® Injectable Drug Information^TM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.

ASHP Injectable Drug Information 2021 now comes complete with 2 years of digital interactive access and a print edition** to ensure you have constant, uninterrupted access. The digital content is interactive, mobile, and updated quarterly. Your 2 years of digital interactive access also includes linked monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information.

Current 2021 edition features:

• 18 new monographs
• Nearly 200 new references
• Over 24,000 total compatibility pairs
   

Other Ways to Access the Content

eBook- New! Now available as an eBook for individual and institutional purchasers.

Institutions- ASHP Injectable Drug Information is available in multiple formats and priced for institutions. Contact Chris Jezowski at cjezowski@ashp.org for more information and for institutional pricing.

Licensing Information-The database can be licensed by healthcare information system developers in formats and with content areas specific to organizational requirements. Content is updated quarterly and available in XML. Visit ashp.org/injectables for more information.

*One package per purchase. For institutional purchases contact Chris Jezowski at cjezowski@ashp.org

**Print + Digital Access is only available with direct purchase from ASHP. Digital access will not be granted when purchased from a third-party.